Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms TV 202, TV202 |
Target- |
Action- |
Mechanism- |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Frontotemporal Dementia | Preclinical | United States | 01 Jan 2025 | |
| Multiple Sclerosis | Preclinical | United States | 01 Jan 2025 |





